O96935 (AMPN_PLAF7) Plasmodium falciparum (isolate 3D7)
Aminopeptidase N UniProtKBInterProSTRINGInteractive Modelling
1085 aa; Sequence (Fasta) ;
11 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
55 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| The crystal structure of PfA-M1 in complex with 7-amino-4-phenyl-5,7,8,9-tetrahydrobenzocyclohepten… | monomer | 1×ZN; 1×7ML; 2×PEG; 2×MLI; 2×NA; | ||||
| Assess | ||||||
| The crystal structure of PfA-M1 in complex with 7-amino-1,4-dibromo-5,7,8,9-tetrahydrobenzocyclohep… | monomer | 1×ZN; 1×L5E; 1×B3P; 1×GOL; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N in complex with actinonin | monomer | 1×ZN; 1×MG; 1×BB2; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N with Magnesium bound to active site Zinc | monomer | 1×ZN; 3×MG; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N in complex with (S)-2-(3-(2,6-diethylph… | monomer | 1×ZN; 2×MG; 1×8LO; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N in complex with (S)-2-(3-(3,4-dimethylb… | monomer | 1×ZN; 3×MG; 1×E8F; 1×E8R; 4×GOL; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N in complex with (S)-N-hydroxy-4-methyl-… | monomer | 1×ZN; 3×MG; 1×GOL; 1×8KR; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N in complex with (S)-2-(3-(2,4-difluorob… | monomer | 3×MG; 1×ZN; 3×GOL; 1×E8C; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N in complex with (S)-N-hydroxy-4-methyl-… | monomer | 1×ZN; 3×MG; 1×8N3; 4×GOL; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N in complex with (S)-2-(3-(2-chlorobenzy… | monomer | 1×ZN; 3×MG; 6×GOL; 1×B1B; | ||||
| Assess | ||||||
| Plasmodium falciparum M1 in complex with inhibitor 15ag | monomer | 6×GOL; 2×DMS; 1×X68; 1×ZN; 2×MG; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N in complex with (S)-2-((2S,3R)-3-amino-… | monomer | 1×ZN; 2×MG; 1×GOL; 1×8KO; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N in complex with (S)-2-((2S,3R)-3-amino-… | monomer | 1×ZN; 3×MG; 11×GOL; 1×89X; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N in complex with (S)-2-(3-(3-chlorobenzy… | monomer | 1×ZN; 3×MG; 1×8L0; | ||||
| Assess | ||||||
| Crystal structure of Plasmodium falciparum aminopeptidase N in complex with (S)-2-(3-(2,3-dimethylb… | monomer | 1×ZN; 3×MG; 1×E8G; 4×GOL; | ||||
| Assess | ||||||
| X-ray crystal structure of Pf-M1 in complex with inhibitor (6h) and catalytic zinc ion | monomer | 1×ZN; 1×J1G; 2×DMS; 3×GOL; 4×MG; | ||||
| Assess | ||||||
| X-ray crystal structure of Pf-M1 in complex with inhibitor (6p) and catalytic zinc ion | monomer | 1×ZN; 1×J6A; 4×MG; 7×GOL; 1×DMS; 1×PO4; | ||||
| Assess | ||||||
| X-ray crystal structure of Pf-M1 in complex with inhibitor (6o) and catalytic zinc ion | monomer | 1×ZN; 1×J4P; 8×GOL; 3×MG; | ||||
| Assess | ||||||
| X-ray crystal structure of the orally available aminopeptidase inhibitor, Tosedostat, bound to the … | monomer | 1×ZN; 1×TOD; 4×MG; 8×GOL; | ||||
| Assess | ||||||
| Plasmodium falciparum M1 aminopeptidase bound to selective inhibitor MIPS2673 | monomer | 1×ZN; 1×BYW; 5×MG; 2×GOL; | ||||
| Assess | ||||||
| X-ray crystal structure of Pf-M1 in complex with inhibitor (6m) and catalytic zinc ion | monomer | 1×ZN; 1×J4S; 5×GOL; 3×PO4; 5×MG; | ||||
| Assess | ||||||
| Plasmodium falciparum M1 in complex with inhibitor 9aa | monomer | 1×ZN; 1×X10; 5×MG; 3×GOL; | ||||
| Assess | ||||||
| Structure of the M1 Alanylaminopeptidase from malaria complexed with bestatin | monomer | 1×ZN; 1×BES; 6×GOL; 4×MG; | ||||
| Assess | ||||||
| X-ray crystal structure of Pf-M1 in complex with inhibitor (6i) and catalytic zinc ion | monomer | 1×ZN; 1×J1V; 5×GOL; 3×MG; 1×PO4; | ||||
| Assess | ||||||
| Plasmodium falciparum M1 in complex with inhibitor 9c | monomer | 1×X0I; 1×DMS; 4×GOL; 1×ZN; 4×MG; | ||||
| Assess | ||||||
| Phosphonic Arginine Mimetics as Inhibitors of the M1 Aminopeptidases from Plasmodium falciparum | monomer | 1×ZN; 2×MG; 3×GOL; 1×1OV; | ||||
| Assess | ||||||
| X-ray crystal structure of PfA-M1 bound to Bestatin derivative 16 | monomer | 1×ZN; 1×D50; 2×GOL; 1×MG; | ||||
| Assess | ||||||
| X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 9b | monomer | 1×4S9; 1×ZN; 2×GOL; 1×MG; 1×PO4; | ||||
| Assess | ||||||
| X-ray crystal structure of PfA-M1 bound to bestatin derivative 15 | monomer | 1×ZN; 4×MG; 4×GOL; 1×D66; | ||||
| Assess | ||||||
| A bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family am… | monomer | 1×ZN; 3×MG; 1×BTJ; | ||||
| Assess | ||||||
| X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 9f | monomer | 1×ZN; 1×4SA; 2×MG; | ||||
| Assess | ||||||
| X-ray crystal structure of Pf-M1 in complex with inhibitor (6da) and catalytic zinc ion | monomer | 1×ZN; 1×J0Y; 5×GOL; 4×MG; | ||||
| Assess | ||||||
| X-ray crystal structure of Pf-M1 in complex with inhibitor (6k) and catalytic zinc ion | monomer | 1×ZN; 1×J4V; 1×PO4; 2×GOL; 4×MG; | ||||
| Assess | ||||||
| Plasmodium falciparum M1 in complex with inhibitor 9aj | monomer | 6×GOL; 4×DMS; 1×X4I; 1×ZN; 4×MG; | ||||
| Assess | ||||||
| X-ray crystal structure of Pf-M1 in complex with inhibitor (6j) and catalytic zinc ion | monomer | 1×ZN; 1×J2D; 2×GOL; 4×MG; 1×PO4; | ||||
| Assess | ||||||
| Phosphonic Arginine Mimetics as Inhibitors of the M1 Aminopeptidases from Plasmodium falciparum | monomer | 1×ZN; 2×GOL; 2×MG; 1×1OS; | ||||
| Assess | ||||||
| X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 10o | monomer | 1×4TL; 1×ZN; 1×MG; 1×PO4; 3×GOL; 3×DMS; | ||||
| Assess | ||||||
| X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 9q | monomer | 1×4SY; 1×ZN; 3×MG; 3×GOL; 4×DMS; 2×PO4; | ||||
| Assess | ||||||
| Phosphonic Arginine Mimetics as Inhibitors of the M1 Aminopeptidases from Plasmodium falciparum | monomer | 2×GOL; 2×MG; 1×ZN; 1×1OT; | ||||
| Assess | ||||||
| Phosphonic Arginine Mimetics as Inhibitors of the M1 Aminopeptidases from Plasmodium falciparum | monomer | 1×ZN; 3×MG; 2×GOL; 1×1OU; | ||||
| Assess | ||||||
| Phosphonic Arginine Mimetics as Inhibitors of the M1 Aminopeptidases from Plasmodium falciparum | monomer | 1×ZN; 1×19N; 1×MG; | ||||
| Assess | ||||||
| X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 10q | monomer | 1×ZN; 1×4TM; 2×MG; 2×DMS; 1×GOL; | ||||
| Assess | ||||||
| Structure of the m1 alanylaminopeptidase from malaria complexed with a hydroxamic acid-based inhibi… | monomer | 1×ZN; 2×DMS; 8×GOL; 1×R5T; | ||||
| Assess | ||||||
| Crystal structure of PfA-M1 with virtual ligand inhibitor | monomer | 1×4QP; 1×ZN; 2×GOL; 1×MG; | ||||
| Assess | ||||||
| Structure of the M1 Alanylaminopeptidase from malaria complexed with the phosphinate dipeptide anal… | monomer | 1×ZN; 1×BEY; 5×GOL; 4×MG; | ||||
| Assess | ||||||
| X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 10b | monomer | 1×ZN; 1×4TK; 2×MG; 2×DMS; | ||||
| Assess | ||||||
| X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 9r | monomer | 1×ZN; 1×4T2; 4×DMS; 2×GOL; | ||||
| Assess | ||||||
| Structure of the M1 Alanylaminopeptidase from malaria | monomer | 1×ZN; 2×MG; 5×GOL; | ||||
| Assess | ||||||
| Structure of the m1 alanylaminopeptidase from malaria complexed with a hydroxamic acid-based inhibi… | monomer | 1×ZN; 1×R5V; 3×GOL; | ||||
| Assess | ||||||
| Plasmodium falciparum M1 in complex with inhibitor 15ah | monomer | 1×GOL; 1×X4O; 1×ZN; | ||||
| Assess | ||||||
| Structure of the m1 alanylaminopeptidase from malaria complexed with a hydroxamic acid-based inhibi… | monomer | 1×ZN; 4×GOL; 1×MG; 1×R5X; 5×DMS; | ||||
| Assess | ||||||
| Plasmodium falciparum M1 in complex with inhibitor 15aa | monomer | 8×GOL; 1×X4T; 2×DMS; 1×ZN; | ||||
| Assess | ||||||
| X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 9m | monomer | 1×ZN; 1×4SZ; 3×MG; 3×GOL; 1×DMS; | ||||
| Assess | ||||||
| X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 10s | monomer | 1×ZN; 1×4U6; 1×MG; 4×DMS; 1×GOL; | ||||
| Assess | ||||||
| A naturally variable residue in the S1 subsite of M1-family aminopeptidases modulates catalytic pro… | monomer | 1×ARG; 1×ZN; 1×MG; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8slo.1.A | monomer | 0.94 | 1×ZN; 1×BYW; | 99.35 | ||
| Assess | ||||||